These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6137396)

  • 1. Dynorphin induces partially reversible paraplegia in the rat.
    Faden AI; Jacobs TP
    Eur J Pharmacol; 1983 Jul; 91(2-3):321-4. PubMed ID: 6137396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
    Faden AI; Jacobs TP
    Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous opioids in spinal cord injury: a critical evaluation.
    Long JB; Martinez-Arizala A; Petras JM; Holaday JW
    Cent Nerv Syst Trauma; 1986; 3(4):295-315. PubMed ID: 2884046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inactivation of opioid receptors in rat hippocampus demonstrates that dynorphin-A and -B may act on mu-receptors in the CA1 region.
    Chavkin C; Henriksen SJ; Siggins GR; Bloom FE
    Brain Res; 1985 Apr; 331(2):366-70. PubMed ID: 2859095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased dynorphin immunoreactivity in spinal cord after traumatic injury.
    Faden AI; Molineaux CJ; Rosenberger JG; Jacobs TP; Cox BM
    Regul Pept; 1985 May; 11(1):35-41. PubMed ID: 2861626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of endogenous opioid peptides in modulation of nocifensive response to formalin.
    Wu HE; Hung KC; Mizoguchi H; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2002 Feb; 300(2):647-54. PubMed ID: 11805228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptides in spinal cord injury: comparative experimental models.
    Faden AI; Jacobs TP; Smith GP; Green B; Zivin JA
    Peptides; 1983; 4(5):631-4. PubMed ID: 6657511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hindlimb paralytic effects of prodynorphin-derived peptides following spinal subarachnoid injection in rats.
    Long JB; Martinez-Arizala A; Echevarria EE; Tidwell RE; Holaday JW
    Eur J Pharmacol; 1988 Aug; 153(1):45-54. PubMed ID: 2905665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurologic deficits and neuronal injury in rats resulting from nonopioid actions of the delta opioid receptor antagonist ICI 174864.
    Long JB; Petras JM; Holaday JW
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1169-77. PubMed ID: 2908046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynorphin A-induced rat hindlimb paralysis and spinal cord injury are not altered by the kappa opioid antagonist nor-binaltorphimine.
    Long JB; Rigamonti DD; de Costa B; Rice KC; Martinez-Arizala A
    Brain Res; 1989 Sep; 497(1):155-62. PubMed ID: 2571391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between highly selective mu and delta opioids in vivo at the rat spinal cord.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    NIDA Res Monogr; 1986; 75():97-100. PubMed ID: 2829017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central cardiovascular effects of kappa agonists dynorphin-(1-13) and ethylketocyclazocine in the anaesthetized rat.
    Laurent S; Schmitt H
    Eur J Pharmacol; 1983 Dec; 96(1-2):165-9. PubMed ID: 6319158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral effects of opioid peptides selective for mu or delta receptors. II. Locomotor activity in nondependent and morphine-dependent rats.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):997-1003. PubMed ID: 3018231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate (NMDA) and opioid receptors mediate dynorphin-induced spinal cord injury: behavioral and histological studies.
    Bakshi R; Ni RX; Faden AI
    Brain Res; 1992 May; 580(1-2):255-64. PubMed ID: 1380394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The occurrence and receptor specificity of endogenous opioid peptides within the pancreas and liver of the rat. Comparison with brain.
    Khawaja XZ; Green IC; Thorpe JR; Titheradge MA
    Biochem J; 1990 Apr; 267(1):233-40. PubMed ID: 1970240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opioids act centrally to modulate stress-induced decrease in luteinizing hormone in the rat.
    Petraglia F; Vale W; Rivier C
    Endocrinology; 1986 Dec; 119(6):2445-50. PubMed ID: 2877862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive action of intracerebroventricularly administered dynorphin and other opioid peptides in the rat.
    Tiseo PJ; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1988 Aug; 246(2):449-53. PubMed ID: 2900324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of opioid peptides selective for mu or delta receptors. I. Morphine-like discriminative stimulus effects.
    Locke KW; Holtzman SG
    J Pharmacol Exp Ther; 1986 Sep; 238(3):990-6. PubMed ID: 3018230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynorphin inhibition of the neurotensin contractile activity on the myenteric plexus.
    Huidobro-Toro JP; Zhu YX; Lee NM; Loh HH; Way EL
    J Pharmacol Exp Ther; 1984 Feb; 228(2):293-303. PubMed ID: 6141281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb.
    Olianas MC; Onali P
    Mol Pharmacol; 1992 Jul; 42(1):109-15. PubMed ID: 1321951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.